Geode Capital Management, LLC Oncolytics Biotech Inc Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 41,942 shares of ONCY stock, worth $31,037. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,942
Previous 41,942
-0.0%
Holding current value
$31,037
Previous $41,000
12.2%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ONCY
# of Institutions
47Shares Held
1.26MCall Options Held
0Put Options Held
0-
International Assets Investment Management, LLC Orlando, FL200KShares$148,2960.02% of portfolio
-
Seeds Investor LLC New York, NY190KShares$140,5560.06% of portfolio
-
Goldman Sachs Group Inc New York, NY101KShares$75,0340.0% of portfolio
-
Virtu Financial LLC New York, NY98.5KShares$72,8540.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il79.2KShares$58,6440.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $42.8M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...